Serum levels of osteoprotegerin increase with age in a healthy adult population
- 23 April 2003
- Vol. 32 (6) , 681-686
- https://doi.org/10.1016/s8756-3282(03)00090-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Osteoprotegerin inhibits prostate cancer–induced osteoclastogenesis and prevents prostate tumor growth in the boneJournal of Clinical Investigation, 2001
- Associations of Serum Osteoprotegerin Levels with Diabetes, Stroke, Bone Density, Fractures, and Mortality in Elderly WomenJournal of Clinical Endocrinology & Metabolism, 2001
- Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly menJournal of Clinical Investigation, 2000
- The Role of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone DiseasesJournal of Clinical Endocrinology & Metabolism, 2000
- Age-Related Decline in Osteoprotegerin Expression by Human Bone Marrow Cells Cultured in Three-Dimensional Collagen SpongesBiochemical and Biophysical Research Communications, 2000
- Estrogen Stimulates Gene Expression and Protein Production of Osteoprotegerin in Human Osteoblastic CellsEndocrinology, 1999
- Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell FormationEndocrinology, 1999
- Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with OsteoporosisJournal of Bone and Mineral Research, 1999
- Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in VitroEndocrinology, 1998
- Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the senieur protocolMechanisms of Ageing and Development, 1990